On May 5th, 2017, the European Medicines Agency (EMA) and the European Commission have published the first information guide for healthcare professionals on biosimilar medicines. This drug category refers to biological medicines highly similar in terms of safety,...
The European Medicines Agency’s (EMA) published the 2016 annual report describing its work and impact in the area of medicines and health during last year. The report highlights the Agency’s key achievements in the areas of medicine evaluation, support to research and...
The new European Paediatric Translational Research Infrastructure (EPTRI) has been presented at the 16th meeting of the European Society for Developmental Perinatal and Pediatric Pharmacology (ESDPPP) Congress, held in Belgium on 20-23 June 2017, in the section "New...
Despite the correct application of blood transfusions and chelation treatments, beta thalassemia patients have many complications. Systematic population analyses on types and frequency of these complications are very few. An article entitled “Pattern of complications...
The e-learning “ICH-Good Clinical Practice (GCP) Training Course”, promoted by Consorzio per Valutazioni Biologiche e Farmacologiche in the framework of the GAPP project, meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified as...
The Second paediatric strategy forum, Medicinal Product Development for Mature B cell Malignancies in Children, jointly organised by ACCELERATE and the European Medicines Agency (EMA), will be held in London at the EMA premises on 13 and 14 November, 2017. The event...
Patients involvement in the development of paediatric clinical trials is recognized as an important added value at European and international level and an essential contribution to paediatric clinical research. To foster patients’ empowerment, advocacy groups...
In December 2016, the European Parliament adopted a Resolution on the Regulation on Paediatric Medicines. TEDDY has contributed to it in providing some suggestions and comments in the drafting phase. The document acknowledges that relevant results have been achieved...
[fusion_builder_container hundred_percent="no" equal_height_columns="no" hide_on_mobile="small-visibility,medium-visibility,large-visibility" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3"...
The Masters Certificate of Professional Development in Medicines Use in Paediatrics and Neonates is certified postgraduate course in advanced paediatric clinical practice, open to all healthcare professionals with an interest in medicines use in paediatrics and...